デフォルト表紙
市場調査レポート
商品コード
1008106

乳房生検の世界市場予測(2020年~2026年)

Breast Biopsy Market 2020-2026

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
乳房生検の世界市場予測(2020年~2026年)
出版日: 2021年05月04日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乳房生検の市場規模は、2021年から2027年までの予測期間中に8.2%のCAGRでかなり拡大すると予想されています。乳房生検は、患部または疑わしい部位から組織を切除する処置です。次に、除去された細胞を顕微鏡で検査し、さらに乳癌の存在を確認するために検査します。生検は、疑わしい部位が癌性であるかどうかを判断できる唯一の診断手順です。生検サンプルは分析のために研究所に送られ、そこで専門家が細胞が癌性であるかどうかを判断します。世界の乳癌市場の成長に貢献する主な要因には、乳癌の高い有病率、乳癌スクリーニングプログラムの増加、低侵襲乳癌検診の採用の増加、および乳癌研究に対する多額の支出などがあります。

さらに、カナダでは、Canadian Cancer Societyによると、2020年に約27,400人の女性が乳癌と診断されました。これは、毎日約75人の新しい乳癌症例に相当する25%の新しい癌症例でした。米国では、女性の8人に1人が生涯で浸潤性乳癌を発症します。このように、症例数の増加により、政府は乳癌の早期発見に対する意識を世界的に高めることを余儀なくされています。さらに、高額な治療、リスク、および乳房生検の有害な影響が市場を抑制しています。真空支援生検などの新技術の導入、有望な臨床試験、女性の意識の向上が、市場機会となっています。

当レポートでは、世界の乳房生検市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最新動向
  • 主要な戦略分析

第4章 市場の決定要因

  • 成長要因
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • タイプ別市場
    • 細針生検
    • コア針生検
    • 外科的生検
    • その他(リンパ節および真空補助生検)
  • 製品別市場
    • 生検針
    • 誘導システム
    • 生検テーブル
    • 位置特定ワイヤー
    • アッセイキット
    • その他
  • ガイド下技術別市場
    • MRIガイド下生検
    • 超音波ガイド下生検
    • マンモグラフィガイド下定位生検
    • CTガイド下生検
    • その他
  • エンドユーザー別市場
    • 病院
    • 診断センター
    • 研究機関

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Co.
  • Benetec Medical Systems
  • Merit Medical Systems
  • Cigna International Corp.
  • Cook Group Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • IMS GIOTTO S.P.A.
  • Leica Biosystems Nussloch GmbH(Devicor Medical Products, Inc.)
  • Medtronic plc
  • NORAS MRI Products GmbH
  • Oncocyte Corp.
  • Planmeca Group
  • QIAGEN GmbH
  • Scion Medical Technologies, LLC.
  • Trivitron Healthcare
  • United Medical Systems Inc.
  • VigeoSRL
図表

LIST OF TABLES

  • 1. GLOBAL BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 2. GLOBAL FINE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CORE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL SURGICAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL OTHERS TYPE BIOPYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 7. GLOBAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL BIOPSY TABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL ASSAY KITFOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL GUIDANCE SYSTEMSFOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL LOCALIZATION WIRESFOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL OTHER FOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 14. GLOBAL MRI-GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL ULTRASOUND GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL CT-GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 20. GLOBAL BREAST BIOPSY IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. GLOBAL BREAST BIOPSY IN DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 22. GLOBAL BREAST BIOPSY IN RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 24. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 25. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT,2020-2027 ($ MILLION)
  • 26. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 27. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 28. EUROPEAN BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 29. EUROPEAN BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 30. EUROPEAN BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 31. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 32. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 34. ASIA-PACIFIC BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 35. ASIA-PACIFIC BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 36. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 37. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 39. REST OF THE WORLD BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 40. REST OF THE WORLD BREAST BIOPSYMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 41. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 42. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BREAST BIOPSYMARKET SHARE BY TYPE,2020 VS 2027 (%)
  • 2. GLOBAL BREAST BIOPSY MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 3. GLOBAL BREAST BIOPSY MARKET SHARE BY GUIDED TECHNOLOGY, 2020 VS 2027 (%)
  • 4. GLOBAL BREAST BIOPSYMARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 5. GLOBAL BREAST BIOPSYMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL FINE NEEDLE BIOPSYMARKETSHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL CORE NEEDLE BIOPSYMARKETSHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL SURGICAL BIOPSYMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL OTHERS BIOPSYMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBALBIOPSY NEEDLESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL BIOPSY TABLES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL ASSAY KIT MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL MRI-GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL GUIDANCE SYSTEMSMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL LOCALIZATION WIRESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL OTHER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL ULTRASOUND GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL MAMMPGRAPHY GUIDED STEROTACTIC BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL CT-GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 20. GLOBAL OTHER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 21. GLOBAL BREAST BIOPSY IN HOSPITALS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 22. GLOBAL BREAST BIOPSY IN DIAGNOSTIC CENTRE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 23. GLOBAL BREAST BIOPSY IN RESAERCH INSTITUTE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 24. US BREAST BIOPSYMARKET SIZE, 2020-2027($ MILLION)
  • 25. CANADA BREAST BIOPSYMARKET SIZE, 2020-2027($ MILLION)
  • 26. UK BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. FRANCE BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 28. GERMANY BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. ITALY BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. SPAIN BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 31. REST OF EUROPE BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. INDIA BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 33. CHINA BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. JAPAN BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. SOUTH KOREA BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
  • 36. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD BREAST BIOPSY MARKETSIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2023399

Global Breast Biopsy Market Size, Share & Trends Analysis Report by Type (Fine Needle Biopsy, Core Needle Biopsy, Surgical Biopsy, and Others (Lymph Node and Vacuum-Assisted Biopsy)), By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kit, and Other), By Guided Technology (MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography Guided Stereotactic Biopsy, CT-Guided Biopsy and Other), By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period 2021-2027

The global breast biopsy market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2021-2027). A breast biopsy is a procedure in which tissues are removed from the affected or suspicious area. The removed cells are then examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is the only diagnostic procedure that can determine if the suspicious area is cancerous. Biopsy samples are sent to a laboratory for analysis where experts determine whether the cells are cancerous. The key factors contributing to the growth of the global breast biopsy market include the high prevalence of breast cancer, increasing breast cancer screening programs, rising adoption of minimally invasive breast biopsies, and high expenditure on breast cancer research.

Further, in Canada, as per the Canadian Cancer Society, in 2020 around 27,400 women were diagnosed with breast cancer, which was 25% new cancer cases that represent around 75 new breast cancer cases were diagnosed every day. In the US, one in eight women develops invasive breast cancer in its lifetime. Thus, the increasing number of cases has forced the government to raise awareness for the early detection of breast cancer globally. Moreover, the high cost of the procedure, risk, and harmful effects of breast biopsy are restraining the market. The introduction of new technologies such as vacuum-assisted biopsy, promising clinical trials, and raising awareness among women are some opportunities for the market.

Segmental Outlook

The global breast biopsy market is segmented based on type, product, guided technology, and end-user. Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy, and others. Further, others type is bifurcated into the lymph node and vacuum-assisted biopsy. The fine needle biopsy has a significant market share during the forecast period due to the rise in the demand for minimally invasive procedures, and the vacuum-assisted biopsy has significant growth during the forecast period owing to the less-invasive nature of this technique which makes a small incision through which needle is inserted. Based on the product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kit, and other. Besides, based on the guided technology, the market is segmented into MRI-guided biopsy, ultrasound-guided biopsy, mammography-guided biopsy, CT-guided biopsy, and others. Apart from it, based on the end-user, the market is segmented into hospitals, diagnostic centers, and research institutes.

Global Breast Biopsy Market Share by Product, 2020 (%)

Source: OMR Global

Biopsy Needles holds a significant share in the Market

The biopsy needles held the major share in 2020 and are also anticipated to grow during the forecast period. The factors such as the rising adoption of image-guided procedures in emerging and developed economies, and the introduction of technologically advanced biopsy needles are driving the market growth during the forecast period. For instance, a pincer needle on the outermost edge, an outer cutting needle, and a sharp stylet on the inner side makes up the tri-axial needle. The needle design allows healthcare professionals to cut through tissue without compressing it. With the specific design of the needle, it is visible under ultrasound and CT, which are widely used for biopsy guidance.

Regional Outlooks

The global breast biopsy market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds a dominant position in the global breast biopsy market, followed by Europe. The growth is mainly due to the prevalence of breast cancer, rising adoption of minimally invasive breast biopsies significantly contributing towards the market growth in the region. For instance, as per the American Cancer Society, in 2021, it an estimated that around 281,550 new cases of invasive breast cancer are expected to be diagnosed in women in the US. Apart from it, around 49,290 new cases of non-invasive breast cancer in the US.

Global Breast Biopsy Market Growth, by Region 2021-2027

Source: OMR Global

Asia-Pacific is projected to have a considerable share in the global breast biopsy market

Asia-Pacific is anticipated to hold a considerable market share in the global breast biopsy market. This is due to increasing breast cancer screening programs. The infrastructure of healthcare in emerging economies such as China, India, and South Korea is evolving at a rapid pace, leading to major investment in advanced systems by hospitals and breast centers is driving the growth of the Asia-Pacific breast biopsy market. Apart from it, the rising prevalence of breast cancer, the rising number of awareness programs for early detection of breast cancer, and the government spending on breast cancer research are the factors that are propelling the market growth in the region. For instance, as per the Organization for Economic Corporation and Development, in 2018, around 839,000 women were diagnosed with breast cancer and more than 286,000 mortalities occurred in the region.

Market Players Outlook

The key players of the breast biopsy market include Becton, Dickson and Co., Danaher Corp., Hologic, Inc., QIAGEN GmbH, F. Hoffman-La Roche Ltd., Argon Medical Devices, Inc., Cigna International, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, geographical expansion, collaborations, and new product launches, to stay competitive in the market. For instance, in May 2019, Argon Medical Devices, Inc., a manufacturer of specialty medical devices announced that it has acquired Mana-Tech Ltd., a distributor for the UK and Ireland. This acquisition was done to expand the commercial reach of argon's products.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global breast biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Opportunity Outlook
  • COVID-19 Impact Analysis
  • Recovery Scenarios
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Breast Biopsy Market by Type
    • 5.1.1. Fine Needle Biopsy
    • 5.1.2. Core Needle Biopsy
    • 5.1.3. Surgical Biopsy
    • 5.1.4. Others (Lymph Node and Vacuum Assisted Biopsy)
  • 5.2. Global Breast Biopsy Market by Product
    • 5.2.1. Biopsy Needles
    • 5.2.2. Guidance Systems
    • 5.2.3. Biopsy Tables
    • 5.2.4. Localization Wires
    • 5.2.5. Assay Kit
    • 5.2.6. Other
  • 5.3. Global Breast Biopsy Marketby Guided Technology
    • 5.3.1. MRI-Guided Biopsy
    • 5.3.2. Ultrasound Guided Biopsy
    • 5.3.3. Mammography Guided Stereotactic Biopsy
    • 5.3.4. CT-Guided Biopsy
    • 5.3.5. Other
  • 5.4. Global Breast Biopsy Marketby End-User
    • 5.4.1. Hospitals
    • 5.4.2. Diagnostic Centre
    • 5.4.3. Research Institute

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Argon Medical Devices, Inc.
  • 7.2. Becton, Dickinson and Co.
  • 7.3. Benetec Medical Systems
  • 7.4. Merit Medical Systems
  • 7.5. Cigna International Corp.
  • 7.6. Cook Group Inc.
  • 7.7. Danaher Corp.
  • 7.8. F. Hoffmann-La Roche Ltd.
  • 7.9. Hologic, Inc.
  • 7.10. IMS GIOTTO S.P.A.
  • 7.11. Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.)
  • 7.12. Medtronic plc
  • 7.13. NORAS MRI Products GmbH
  • 7.14. Oncocyte Corp.
  • 7.15. Planmeca Group
  • 7.16. QIAGEN GmbH
  • 7.17. Scion Medical Technologies, LLC.
  • 7.18. Trivitron Healthcare
  • 7.19. United Medical Systems Inc.
  • 7.20. VigeoSRL